thyroxine has been researched along with Venous Thrombosis in 10 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We determined the associations of levels of free thyroxine (FT4), thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase antibodies (antiTPO) with levels of coagulation factors and the risk of venous thrombosis." | 7.80 | High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study. ( Brandjes, DP; Büller, HR; Cannegieter, SC; Debeij, J; Dekkers, OM; Doggen, CJ; Gerdes, VE; Rosendaal, FR; Smit, JW; van Zaane, B; van Zanten, AP, 2014) |
| "Relative and absolute risks for venous thrombosis were calculated for different cut-off levels of thyroid hormones on the basis of percentiles in the controls and different times between blood sampling and thombosis." | 5.38 | Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. ( Asvold, BO; Cannegieter, SC; Christiansen, SC; Debeij, J; Dekkers, OM; Hammerstrom, J; Naess, IA; Rosendaal, FR, 2012) |
| " We determined the associations of levels of free thyroxine (FT4), thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase antibodies (antiTPO) with levels of coagulation factors and the risk of venous thrombosis." | 3.80 | High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study. ( Brandjes, DP; Büller, HR; Cannegieter, SC; Debeij, J; Dekkers, OM; Doggen, CJ; Gerdes, VE; Rosendaal, FR; Smit, JW; van Zaane, B; van Zanten, AP, 2014) |
| " We present a case of primary hypothyroidism who presented with euvolemic hyponatremia and DVT that required thyroxine replacement and correction of hyponatremia." | 3.77 | Deep vein thrombosis and euvolemic hyponatremia in a hypothyroid patient. ( Kumar, SS; Prasad, CV; Rajesh, J; Shakir, RM; Umadevi, V; Vijayashankar, C, 2011) |
| "This implies an increased risk of venous thrombosis during hyperthyroidism." | 2.76 | Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. ( Brandjes, DP; Büller, HR; Cannegieter, SC; Debeij, J; Dekkers, OM; Gerdes, VE; Meijers, JC; Squizzato, A; Van Zaane, B; Van Zanten, AP, 2011) |
| "Hypothyroidism is associated with an increased bleeding risk, whereas hyperthyroidism leads to an increased risk of venous thrombosis." | 2.58 | Thyroid Disorders and Hemostasis. ( Elbers, LPB; Gerdes, VEA; Squizzato, A, 2018) |
| "A personal history of malignancy and type 2 diabetes increase the risk of PMVT." | 1.48 | Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. ( Blanco, DG; Boyce, SG; De La Cruz-Munoz, N; Domkowski, P; Funes, DR; Ghanem, M; Jawad, MA; Menzo, EL; Moon, RC; Radecke, J; Rosenthal, R; Teixeira, AF; Young, MK, 2018) |
| "Relative and absolute risks for venous thrombosis were calculated for different cut-off levels of thyroid hormones on the basis of percentiles in the controls and different times between blood sampling and thombosis." | 1.38 | Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. ( Asvold, BO; Cannegieter, SC; Christiansen, SC; Debeij, J; Dekkers, OM; Hammerstrom, J; Naess, IA; Rosendaal, FR, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, RC | 1 |
| Ghanem, M | 1 |
| Teixeira, AF | 1 |
| De La Cruz-Munoz, N | 1 |
| Young, MK | 1 |
| Domkowski, P | 1 |
| Radecke, J | 1 |
| Boyce, SG | 1 |
| Rosenthal, R | 1 |
| Menzo, EL | 1 |
| Blanco, DG | 1 |
| Funes, DR | 1 |
| Jawad, MA | 1 |
| Elbers, LPB | 1 |
| Squizzato, A | 3 |
| Gerdes, VEA | 1 |
| Raps, M | 1 |
| Curvers, J | 1 |
| Helmerhorst, FM | 1 |
| Ballieux, BE | 1 |
| Rosing, J | 1 |
| Thomassen, S | 1 |
| Rosendaal, FR | 3 |
| van Vliet, HA | 1 |
| Debeij, J | 3 |
| van Zaane, B | 3 |
| Dekkers, OM | 3 |
| Doggen, CJ | 1 |
| Smit, JW | 1 |
| van Zanten, AP | 3 |
| Brandjes, DP | 3 |
| Büller, HR | 3 |
| Gerdes, VE | 3 |
| Cannegieter, SC | 4 |
| Huijgen, R | 1 |
| Fliers, E | 1 |
| Meijers, JC | 1 |
| Umadevi, V | 1 |
| Rajesh, J | 1 |
| Kumar, SS | 1 |
| Shakir, RM | 1 |
| Vijayashankar, C | 1 |
| Prasad, CV | 1 |
| Asvold, BO | 1 |
| Christiansen, SC | 1 |
| Naess, IA | 1 |
| Hammerstrom, J | 1 |
| Füessl, HS | 1 |
| Vaidya, B | 1 |
| Coulthard, A | 1 |
| Goonetilleke, A | 1 |
| Burn, DJ | 1 |
| James, RA | 1 |
| Kendall-Taylor, P | 1 |
1 review available for thyroxine and Venous Thrombosis
| Article | Year |
|---|---|
Thyroid Disorders and Hemostasis.
Topics: Goiter; Hemostasis; Humans; Hypothyroidism; Risk Factors; Thrombophilia; Thyroxine; Venous Thrombosi | 2018 |
1 trial available for thyroxine and Venous Thrombosis
| Article | Year |
|---|---|
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Cross-Over Studies; Female; Fibrinolysis; Human | 2011 |
8 other studies available for thyroxine and Venous Thrombosis
| Article | Year |
|---|---|
Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study.
Topics: Adult; Aged; Anticoagulants; Bariatric Surgery; Drug Therapy, Combination; Enoxaparin; Epidemiologic | 2018 |
Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Or | 2014 |
High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Case-Control Stud | 2014 |
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Case-Control Studies; Conf | 2010 |
Deep vein thrombosis and euvolemic hyponatremia in a hypothyroid patient.
Topics: Diagnosis, Differential; Female; Fibrinolytic Agents; Heparin; Humans; Hyponatremia; Hypothyroidism; | 2011 |
Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Case-Control Studies; Female; Humans; Lo | 2012 |
[Also in pregnancy the family practitioner is consulted].
Topics: Anti-Bacterial Agents; Anticoagulants; Antithyroid Agents; Bacterial Infections; Family Practice; Fe | 2007 |
Cerebral venous sinus thrombosis: a late sequel of invasive fibrous thyroiditis.
Topics: Cerebral Veins; Female; Fibrosis; Heparin; Humans; Jugular Veins; Magnetic Resonance Angiography; Ma | 1998 |